Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Low Socioeconomic Status Confers Poorer Real-World Overall Survival for Patients with Acute Myeloid Leukemia Treated in the Modern Era

Mark A Guinter, Brendan T Kerr, Gregory S Calip, Anita J Kumar, Ahmed Sawas

Blood (2023) 142 (Supplement 1): 2437.

https://doi.org/10.1182/blood-2023-186137

Published: 2023

Journal Articles

Multi-Level Factors Underlying Racial/Ethnic Inequities in Clinical Trial Participation Among Patients with Hematologic Cancers: Lessons for the Development of Diversity Plans

Jenny S Guadamuz, Harlan Pittell, Amy Pierre, Cleo A Ryals, Gene Ho, Gregory S Calip

Blood (2023) 142 (Supplement 1): 2393.

https://doi.org/10.1182/blood-2023-189897

Published: 2023

Journal Articles

Inequities in Autologous Stem Cell Transplantation, Chimeric Antigen Receptor T-Cell Therapy and Clinical Trial Participation in Patients Receiving Second-Line and Later Multiple Myeloma Treatment

Amy Pierre, Gregory S Calip, Gene Ho, Majd T Ghanim, Yichen Lu, Cleo A Ryals, Jenny S Guadamuz

Blood (2023) 142 (Supplement 1): 2399.

https://doi.org/10.1182/blood-2023-186324

Published: 2023

Journal Articles

External validity of lymphoma clinical trials

Gregory S. Calip, Trevor J. Royce

Blood (2023) 142 (9): 757–759.

https://doi.org/10.1182/blood.2023021222

Published: 2023

Journal Articles

Chronic Opioid Use Is Highly Prevalent and Associated with Inferior Survival in Myeloma Patients in Remission after Autologous Transplant

Karen Sweiss, Craig C Hofmeister, John G. Quigley, Jaleel G. Sweis, Kaily Kurzweil, Douglas W. Sborov, Lisa Sharp, Gregory S Calip, Lucas Maahs, Ana Maria Avila, Chukwuemeka Uzoka, Elizabeth Ilo, Elliot Wolf, Damiano Rondelli, Pritesh Patel

Blood (2022) 140 (Supplement 1): 5252–5253.

https://doi.org/10.1182/blood-2022-171045

Published: 2022

Journal Articles

A Phase Ib Study of the Safety and Efficacy of Venetoclax When Combined with Escalating Doses of Omacetaxine in Patients with Relapsed/Refractory Acute Myeloid Leukemia Failing Treatment with Venetoclax-Containing Regimens (VEN-OM)

Ana Maria Avila, Saad Arain, Karen Sweiss, Pritesh Patel, Samin Houshyar, Gregory S Calip, Irum Khan, Paul G. Rubinstein, Chukwuemeka Uzoka, John G. Quigley

Blood (2022) 140 (Supplement 1): 11774–11775.

https://doi.org/10.1182/blood-2022-165565

Published: 2022

Journal Articles

Updated Analyses: Safety and Efficacy of Gemtuzumab Ozogamicin and Venetoclax in Patients with Relapsed or Refractory CD33+ Acute Myeloid Leukemia: A Phase Ib/II Study

Saad Arain, Ana Maria Avila, Sonia Christian, Pritesh Patel, Karen Sweiss, Brian Parkin, Santosh L. Saraf, Paul G. Rubinstein, Gregory S Calip, John G. Quigley

Blood (2022) 140 (Supplement 1): 11725–11726.

https://doi.org/10.1182/blood-2022-165615

Published: 2022

Journal Articles

Impacts of the COVID-19 Pandemic on Assessment of M-Protein and Free Light Chain Levels in Patients with Multiple Myeloma

James Roose, Yichen Lu, Amy E Pierre, Ahmed Sawas, Gregory S Calip

Blood (2022) 140 (Supplement 1): 13191–13193.

https://doi.org/10.1182/blood-2022-159044

Published: 2022

Journal Articles

Chronic Opioid Use Is Highly Prevalent in Patients Undergoing Allogeneic Transplant and Impacts Long Term Outcomes

Karen Sweiss, Kaily Kurzweil, Gregory S Calip, Lisa Sharp, Nadia Nabulsi, Mahir Khan, Damiano Rondelli, Pritesh R Patel

Blood (2021) 138 (Supplement 1): 1823.

https://doi.org/10.1182/blood-2021-154472

Published: 2021

Journal Articles

Racial Disparities in the Diagnostic Evaluation of Multiple Myeloma

Lucia D Notardonato, Spencer S Langerman, Jifang Zhou, Gregory S Calip, Brian C-H Chiu, Ben A Derman

Blood (2021) 138 (Supplement 1): 4116.

https://doi.org/10.1182/blood-2021-146910

Published: 2021

Journal Articles

Racial and Age-Related Differences in Impacts of High-Risk Cytogenetic Abnormalities on Survival in Multiple Myeloma in a Nationwide Electronic Health Record-Derived Database

Gregory S Calip, Mustafa S Ascha, Xiaoliang Wang, Amy E Pierre, Kathleen Maignan, Niquelle B Wadé, Siyang Leng, Erlene K Seymour, Brian C-H Chiu, Karen Sweiss, Pritesh R Patel, Natalia Neparidze

Blood (2021) 138 (Supplement 1): 4121.

https://doi.org/10.1182/blood-2021-152774

Published: 2021

Journal Articles

Social and Demographic Factors Contributing to COVID-19 Vaccine Hesitancy in Patients with Hematologic Malignancies

Karen Sweiss, Meredith Russell, Gregory S Calip, Ryan Nguyen, Meshaal Khan, Eshana Shah, Ronald Ng, Kaily Kurzweil, Mahir Khan, Ammarah Nadeem, Lisa Wendt, Nicole Fuchs, Elaine Trinh, Damiano Rondelli, Pritesh R Patel

Blood (2021) 138 (Supplement 1): 841.

https://doi.org/10.1182/blood-2021-154339

Published: 2021

Journal Articles

Improved Survival in African American Patients Undergoing Autologous Transplant for Multiple Myeloma in the Chemotherapy and Novel Agent Era

Karen Sweiss, PharmD, Annie L. Oh, MD, Gregory S. Calip, PharmD, MPH, PhD, Damiano Rondelli, MD, Pritesh R. Patel, MD

Blood (2016) 128 (22): 4631.

https://doi.org/10.1182/blood.V128.22.4631.4631

Published: 2016

Journal Articles

Racial Differences in Long-Term Risk of Venous Thromboembolism Among Older Patients Following Diagnosis and Treatment of Multiple Myeloma

Sruthi Adimadhyam, MS, Karen Sweiss, PharmD, Pritesh R. Patel, MD, Brian C.-H. Chiu, PhD, Gregory S. Calip, PharmD, MPH, PhD

Blood (2016) 128 (22): 2071.

https://doi.org/10.1182/blood.V128.22.2071.2071

Published: 2016

Journal Articles

Race and Socioeconomic Factors Influencing Treatment Disparities and Comparative Effectiveness in Very Elderly Patients with Diffuse Large B-Cell Lymphoma

Gregory S. Calip, PharmD, MPH, PhD, Sruthi Adimadhyam, MS, Pritesh R. Patel, MD, Karen Sweiss, PharmD, Ashley B. Cha, BA, Benjamin J. Nagy, BS, Kellyn M. Moran, PharmD, Sonali M. Smith, MD, Brian C.-H. Chiu, PhD

Blood (2016) 128 (22): 841.

https://doi.org/10.1182/blood.V128.22.841.841

Published: 2016

Journal Articles

Risk of Non-Hodgkin Lymphoma Following Treatment of Inflammatory Conditions with Tumor Necrosis Factor-Alpha Inhibitors

Gregory S. Calip, PharmD, MPH, PhD, Wan-Ju Lee, MS, Todd A. Lee, PharmD, PhD, Glen T. Schumock, PharmD, MBA, PhD, Brian C.-H. Chiu, PhD

Blood (2015) 126 (23): 2653.

https://doi.org/10.1182/blood.V126.23.2653.2653

Published: 2015

Journal Articles

Long Term Statin Use and Risk of Multiple Myeloma Among 15.5 Million Taiwanese Adults: A Retrospective Cohort Study

Brian C.-H. Chiu, PhD, Jin-Hua Chen, PhD, Yu-Chun Yen, MS, Gregory S. Calip, PharmD, MPH, PhD, Chun-Ru Chien, MD PhD, Habibul Ahsan, MD MMedSc, Ya-Chen T Shih, PhD, Kuang-Fu Cheng, PhD

Blood (2015) 126 (23): 4198.

https://doi.org/10.1182/blood.V126.23.4198.4198

Published: 2015

Journal Articles

Tumor Necrosis Factor-Alpha Inhibitor Medications for Inflammatory Conditions and Incidence of Multiple Myeloma

Gregory S. Calip, PharmD, MPH, PhD, Wan-Ju Lee, MS, Todd A. Lee, PharmD, PhD, Glen T. Schumock, PharmD, MBA, PhD, Brian C.-H. Chiu, PhD

Blood (2015) 126 (23): 2954.

https://doi.org/10.1182/blood.V126.23.2954.2954

Published: 2015

NARROW

Low Socioeconomic Status Confers Poorer Real-World Overall Survival for Patients with Acute Myeloid Leukemia Treated in the Modern Era

Multi-Level Factors Underlying Racial/Ethnic Inequities in Clinical Trial Participation Among Patients with Hematologic Cancers: Lessons for the Development of Diversity Plans

Inequities in Autologous Stem Cell Transplantation, Chimeric Antigen Receptor T-Cell Therapy and Clinical Trial Participation in Patients Receiving Second-Line and Later Multiple Myeloma Treatment

External validity of lymphoma clinical trials

Chronic Opioid Use Is Highly Prevalent and Associated with Inferior Survival in Myeloma Patients in Remission after Autologous Transplant

A Phase Ib Study of the Safety and Efficacy of Venetoclax When Combined with Escalating Doses of Omacetaxine in Patients with Relapsed/Refractory Acute Myeloid Leukemia Failing Treatment with Venetoclax-Containing Regimens (VEN-OM)

Updated Analyses: Safety and Efficacy of Gemtuzumab Ozogamicin and Venetoclax in Patients with Relapsed or Refractory CD33+ Acute Myeloid Leukemia: A Phase Ib/II Study

Impacts of the COVID-19 Pandemic on Assessment of M-Protein and Free Light Chain Levels in Patients with Multiple Myeloma

Chronic Opioid Use Is Highly Prevalent in Patients Undergoing Allogeneic Transplant and Impacts Long Term Outcomes

Racial Disparities in the Diagnostic Evaluation of Multiple Myeloma

Racial and Age-Related Differences in Impacts of High-Risk Cytogenetic Abnormalities on Survival in Multiple Myeloma in a Nationwide Electronic Health Record-Derived Database

Social and Demographic Factors Contributing to COVID-19 Vaccine Hesitancy in Patients with Hematologic Malignancies

Improved Survival in African American Patients Undergoing Autologous Transplant for Multiple Myeloma in the Chemotherapy and Novel Agent Era

Racial Differences in Long-Term Risk of Venous Thromboembolism Among Older Patients Following Diagnosis and Treatment of Multiple Myeloma

Race and Socioeconomic Factors Influencing Treatment Disparities and Comparative Effectiveness in Very Elderly Patients with Diffuse Large B-Cell Lymphoma

Risk of Non-Hodgkin Lymphoma Following Treatment of Inflammatory Conditions with Tumor Necrosis Factor-Alpha Inhibitors

Long Term Statin Use and Risk of Multiple Myeloma Among 15.5 Million Taiwanese Adults: A Retrospective Cohort Study

Tumor Necrosis Factor-Alpha Inhibitor Medications for Inflammatory Conditions and Incidence of Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only